Paracetamol (Acetaminophen) Price Trend & Forecast

Name: Paracetamol (Acetaminophen) Price Trend, Analysis and Forecast
Creator: Price Watch
Published: 2026-02-10
License: https://www.price-watch.ai/terms-conditions/

No matching categories found.

paracetamol (acetaminophen) Price Trends by Country

China

India

Spain

United States

Vietnam

Brazil

Global Paracetamol (Acetaminophen) Spot Market Prices, Chart, Trend Analysis And Forecast

Price Watch™ provides real-time price assessments and price forecasts for Paracetamol (Acetaminophen) across top trading regions:

Paracetamol (Acetaminophen) Regional Coverage	Paracetamol (Acetaminophen) Grade and Country Coverage	Paracetamol (Acetaminophen) Pricing Data Coverage Explanation
Asia-Pacific Paracetamol (Acetaminophen) Pricing Analysis	Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (POWDER) Ex-Vadodara Domestic Prices, India	Weekly Price Update of Paracetamol (Acetaminophen) Real-Time Domestic Prices in Vadodara, India
	Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (POWDER) Ex-Ludhiana Domestic Prices, India	Weekly Price Update of Paracetamol (Acetaminophen) Real-Time Domestic Prices in Ludhiana, India
	Paracetamol (Acetaminophen) Pharma Grade (EP) (>99%) (POWDER) FOB Hyderabad ICD Prices at Hyderabad, India	Weekly Price Update on Paracetamol (Acetaminophen) Real-Time Export Prices from Hyderabad ICD, India to Global Markets
	Paracetamol (Acetaminophen) Pharma Grade (EP) (>99%) (POWDER) FOB Nhava Sheva Prices at Mumbai, India	Weekly Price Update on Paracetamol (Acetaminophen) Real-Time Export Prices from Mumbai, India to Global Markets
	Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (POWDER) Ex-Hebei Domestic Prices, China	Weekly Price Update of Paracetamol (Acetaminophen) Real-Time Domestic Prices in Hebei, China
	Paracetamol (Acetaminophen) Pharma Grade (EP) (>99%) (POWDER) FOB Tianjin Prices at Tianjin, China	Weekly Price Update on Paracetamol (Acetaminophen) Real-Time Export Prices from Tianjin, China to Global Markets
	Paracetamol (Acetaminophen) Pharma Grade (EP) (>99%) (POWDER) CIF Prices at Haiphong Port, Vietnam Importing from China	Weekly Price Update on Paracetamol (Acetaminophen) Real-Time Import Prices at Haiphong, Vietnam from China
Europe Paracetamol (Acetaminophen) Pricing Analysis	Paracetamol (Acetaminophen) Pharma Grade (EP) (>99%) (POWDER) CIF Prices at Valenica Port, Spain Importing from India	Weekly Price Update on Paracetamol (Acetaminophen) Real-Time Import Prices at Valencia, Spain from India
North America Paracetamol (Acetaminophen) Pricing Analysis	Paracetamol (Acetaminophen) Pharma Grade (EP) (>99%) (POWDER) CIF Prices at New York Port, USA Importing from India	Weekly Price Update on Paracetamol (Acetaminophen) Real-Time Import Prices at New York, USA from India
South America Paracetamol (Acetaminophen) Pricing Analysis	Paracetamol (Acetaminophen) Pharma Grade (EP) (>99%) (POWDER) CIF Prices at Santos Port, Brazil Importing from China	Weekly Price Update on Paracetamol (Acetaminophen) Real-Time Import Prices at Santos, Brazil, from China

Paracetamol (Acetaminophen) Price Forecasts & Market Foresight Q4 2026

Outlook: Stable to Mildly Bearish

Confidence: Medium

Paracetamol (Acetaminophen) prices are expected to follow a mixed but largely stable trend during Q4 2026, with regional differences driven by inventory levels, export competitiveness, and pharmaceutical procurement. Indian domestic prices may receive support from replenishment demand and production-cost pressures, although adequate availability and competition among manufacturers could limit gains.

Chinese prices are likely to remain relatively firm as producers balance export orders with domestic supply, while pre-Lunar New Year purchasing may support demand toward the end of the quarter. European import prices could strengthen modestly if buying activity improves, whereas North American prices are expected to remain broadly stable under contract-based procurement. Brazil and Vietnam may continue to see competitive Chinese offers, keeping import prices under pressure.

Global Paracetamol (Acetaminophen) Market Overview by Region (October-December 2026)

Country	Grade/ Incoterm	Outlook
India	Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (POWDER) Ex-Vadodara	Stable to Mildly Bullish
India	Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (POWDER) Ex-Ludhiana	Stable
India	Paracetamol (Acetaminophen) Pharma Grade (EP) (>99%) (POWDER) FOB Hyderabad ICD	Stable to Mildly Bullish
India	Paracetamol (Acetaminophen) Pharma Grade (USP) (>99%) (POWDER) FOB Nhava Sheva	Stable to Mildly Bearish
Spain	Paracetamol (Acetaminophen) Pharma Grade (EP) (>99%) (POWDER) CIF Valencia (INDIA)	Stable to Mildly Bullish
USA	Paracetamol (Acetaminophen) Pharma Grade (USP) (>99%) (POWDER) CIF New York (INDIA)	Stable
China	Paracetamol (Acetaminophen) Pharma Grade (USP) (>99%) (POWDER) Ex-Hebei	Stable to Bullish
China	Paracetamol (Acetaminophen) Pharma Grade (USP) (>99%) (POWDER) FOB Tianjin	Stable to Mildly Bullish
Vietnam	Paracetamol (Acetaminophen) Pharma Grade (USP) (>99%) (POWDER) CIF Haiphong (CHINA)	Stable
Brazil	Paracetamol (Acetaminophen) Pharma Grade (USP) (>99%) (POWDER) CIF Santos (CHINA)	Stable to Bearish

*Paracetamol (Acetaminophen) Forecast represents an analytical assessment based on information available at the time of publication. Actual market prices may vary due to unforeseen operational, regulatory, geopolitical, or economic developments.

Explore the Complete Price Watch™ Paracetamol (Acetaminophen) Forecast

Access comprehensive Paracetamol (Acetaminophen) market intelligence, including a 3-Month Rolling Forecast, 12-Month Price Forecast, forward price curves, country-wise market outlooks, procurement insights, and monthly forecast updates.

Explore Price Watch™ Paracetamol (Acetaminophen) Forecasts

What’s Included

The 3-Month Forecast (Updated Monthly)

It reflects changes in phenol and nitro chlorobenzene feedstock costs, energy prices, producer operating rates, plant outages, inventory levels, trade flows, freight rates, regional demand, and geopolitical developments affecting the global Paracetamol (Acetaminophen) market.

The 12-Month Forecast (Published Annually)

It provides a strategic outlook based on expected capacity additions, supply-demand balances, feedstock economics, macroeconomic conditions, industrial production trends, trade policies, seasonal demand patterns, and long-term supply chain developments, supporting procurement, budgeting, and strategic planning.

Our Proprietary Hybrid Forecasting Model Evaluates:

Feedstock & production economics
Plant operating rates & outages
Inventory and supply-demand balance
Regional trade flows & freight
Import-export dynamics
Macroeconomic & geopolitical developments

Track Paracetamol (Acetaminophen) Supply Disruptions in Real Time

As geopolitical risks continue to reshape global supply chains, stay ahead of the events that drive price movements by monitoring plant shutdowns, maintenance turnarounds, force majeure events, logistics bottlenecks, trade restrictions, and operational disruptions before they impact Paracetamol (Acetaminophen) markets.

Access the Price Watch™ GIO Tracker

Paracetamol (Acetaminophen) Price Trend Q3 2026

In Q3 2026, Paracetamol (Acetaminophen) Pharma Grade (>99%) price chart across key global markets recorded mixed movements, ranging approximately from -3.36% to +0.92%, primarily influenced by cautious pharmaceutical procurement, inventory management, competitive supplier quotations, regular import requirements, and varying domestic and export demand conditions.

In China, the Paracetamol price index declined slightly amid controlled inventories and cautious export purchasing, while India recorded a quarterly decrease due to selective domestic procurement and restrained replenishment.

Imported markets including Spain, USA, Vietnam, and Brazil remained broadly stable with minor changes in landed costs and steady pharmaceutical demand limiting significant price movements.

In September 2026, prices across all markets increased, ranging from approximately +3.12% to +4.66% as renewed restocking, improved import purchasing and firmer supplier quotations supported a recovery in market value.

China: Paracetamol (Acetaminophen) Export Prices FOB Tianjin, China, Pharma Grade (USP) (>99%) (POWDER)

In Q3 2026, Paracetamol (Acetaminophen) prices in China decreased by 0.45% compared to the previous quarter. The slight decline is driven by cautious procurement from overseas pharmaceutical buyers, controlled inventory levels, and competitive export offers among Chinese suppliers.

Manufacturers faced pressure to maintain order volumes while buyers focused on immediate requirements rather than building additional stocks. The Paracetamol (Acetaminophen) price trend in China reflected a largely stable market with limited downward pressure during the quarter.

In September 2026, Paracetamol (Acetaminophen) prices in China increased by +4.08%, supported by improved export inquiries, renewed purchasing interest, and firmer supplier quotations as buyers returned to the market to replenish stocks.

India: Paracetamol (Acetaminophen) Domestically Traded prices in Ex-Vadodara, India, Pharma Grade (IP) (>99%) (POWDER)

In the quarter of 2026, the prices of Paracetamol (Acetaminophen) in India go down by 3.36% when compared to the quarter before. This is because the pharmaceutical manufacturers are being careful with their purchases. There is need to restock inventory.

The buyers are looking at the stock they already has. They are negotiating hard with the suppliers. The local producers have to try to keep their order volumes up even though the purchasing activity is not as strong. The Paracetamol (Acetaminophen) price trend in India showed a market feeling and buying that is done only when necessary in the pharmaceutical industry.

In September 2026 Paracetamol (Acetaminophen) price in India go up by 3.12%. This is because there is buying from the pharmaceutical manufacturers. There is restocking activity. The suppliers are asking for prices as the buyers came back to get what they needed for the next few months.

Spain: Paracetamol (Acetaminophen) Imported prices CIF Valencia from India, Spain; Pharma Grade (EP) (>99%) (POWDER)

In the quarter of 2026, Paracetamol (Acetaminophen) prices in Spain go up by 0.07% compared with the previous quarter. The Paracetamol (Acetaminophen) price trend in Spain stayed mostly the same because demand for medicines is steady and import rules stayed the same. Importers kept buying enough to satisfy the needs of medicine makers and people who mix medicines.

Because suppliers competed and buying volumes stayed regular prices do not change much. The Paracetamol (Acetaminophen) price chart showed a steady market. The price index moved a little because demand and supply are balanced.

International product availability, shipping costs and supplier quotes still has a role in CIF pricing. In September 2026 Paracetamol (Acetaminophen) prices in Spain rose by 3.30% compared with the month. This rise is helped by import buying, higher supplier offers and the need for pharmaceutical buyers to restock.

USA: Paracetamol (Acetaminophen) Imported prices CIF New York from India, USA; Pharma Grade (USP) (>99%) (POWDER)

According to Price Watch™, in the quarter of 2026, the price of Paracetamol (Acetaminophen) in the USA go down by 1.30% compared to the previous quarter. The Paracetamol (Acetaminophen) price trend in the USA stayed mostly steady even though there is a downward push because pharmaceutical importers are being careful with how they bought and managed their inventory.

Buyers are focused on making sure they has Paracetamol (Acetaminophen) to meet their production and distribution needs. At the time competitive offers from suppliers and careful buying kept prices from going up too much. The price chart for Paracetamol (Acetaminophen) showed a drop during the quarter.

The price index is affected by use of medicines and continued import activity. Conditions in the supply chain, shipping costs and the total cost of getting the product to the USA kept influencing the CIF prices.

In September 2026 Paracetamol (Acetaminophen) prices in the USA go up by 3.61% compared to the month.This increase is because there is demand, for imports, more restocking and suppliers are asking for higher prices.

Vietnam: Paracetamol (Acetaminophen) Imported prices CIF Haiphong from China, Vietnam; Pharma Grade (USP) (>99%) (POWDER)

In the quarter of 2026 Paracetamol (Acetaminophen) prices in Vietnam rose by 0.16% compared to the previous quarter. The Paracetamol (Acetaminophen) price trend in Vietnam remained largely stable because regular demand for medicines and steady import needs kept the market active.

Importers continued to buy Paracetamol (Acetaminophen) to satisfy formulation and manufacturing demands while competitive offers from Chinese suppliers kept large price swings at bay. The Paracetamol (Acetaminophen) price chart showed a steady market with the price index backed by ongoing consumption and routine import activity.

Freight costs, shipment schedules and supplier quotations still shaped the CIF Haiphong price for Paracetamol (Acetaminophen). In September 2026 Paracetamol (Acetaminophen) prices in Vietnam rose 4.66% from the month driven by fresh restocking demand stronger export offers from China and higher import buying costs.

Brazil: Paracetamol (Acetaminophen) Imported prices CIF Santos from China, Brazil; Pharma Grade (USP) (>99%) (POWDER)

In the quarter of 2026, the price of Paracetamol (Acetaminophen) in Brazil go up by 0.92% when compared to the previous quarter. The Paracetamol (Acetaminophen) price trend in Brazil stayed a little strong helped by the requirements for importing medicines and the steady demand from companies that make and distribute medicine.

Importers kept buying to meet the needs of the companies that make medicines. The prices offered by suppliers and the costs to bring the product into the country affected the CIF pricing. The Paracetamol (Acetaminophen) price chart showed a rise during the quarter with the price index backed by steady buying and continued import demand.

Costs for moving the product when it is shipped and offers from China to export also played a role in the cost of bringing Paracetamol (Acetaminophen) into Brazil. In September 2026 Paracetamol (Acetaminophen) price in Brazil go up by 4.30% compared to the month showing more buying of imports need to restock and stronger prices, from suppliers.

Paracetamol (Acetaminophen) Price Trend Analysis: Q2 2026

Paracetamol (Acetaminophen) Price Trend Q2 2026

In Q2 2026, Paracetamol (Acetaminophen) Pharma Grade (>99%) prices across key global markets recorded increases ranging approximately 4% to 11%, primarily supported by stronger pharmaceutical demand, active domestic and export procurement, regular import requirements, improved inventory absorption, and relatively firm international supply conditions.

In China, healthy export demand and controlled inventories supported the increase, while India recorded the strongest quarterly rise amid tight availability and sustained domestic replenishment. Imported markets including Spain, USA, Vietnam, and Brazil also reflected higher landed costs, supported by international prices and freight conditions, although ample availability and cautious procurement limited the extent of gains in some markets.

In June 2026, prices across most markets showed comparatively moderate movements, ranging from approximately -1.6% to +1.4%, as earlier restocking, improved inventories, and more cautious buying activity tempered the broader quarterly upward momentum.

China: Paracetamol (Acetaminophen) Export Prices FOB Tianjin, China, Pharma Grade (USP) (>99%) (POWDER)

In the quarter of 2026 Paracetamol (Acetaminophen) prices in China rose by 4.09% from the previous quarter. Paracetamol (Acetaminophen) price rise is helped by export demand, steady procurement from overseas pharmaceutical manufacturers and balanced supply conditions.

Manufacturers kept operating rates and controlled inventories and increased buying interest gave extra support to market sentiment. Paracetamol (Acetaminophen) price trend in China showed market fundamentals, backed by healthy export competitiveness and stable production during the whole quarter.

In June 2026 Paracetamol (Acetaminophen) prices in China go up by 1.46%. This rise came from export inquiries ongoing procurement activity and tighter spot availability leading to a modest month‑end price increase.

India: Paracetamol (Acetaminophen) Domestically Traded prices in Ex-Vadodara, India, Pharma Grade (IP) (>99%) (POWDER)

In the quarter of 2026 the Paracetamol (Acetaminophen) price in India go up by 10.93% compared with the previous quarter. This rise is helped by demand inside the country active buying by the makers of medicine and better absorption of stock.

Limited supply of the product. Steady costs of making it made the market feel confident. Most of the quarter people kept buying so prices stayed high. The Paracetamol (Acetaminophen) price trend in India showed that people are still using it a lot and that the stock is being refilled, which kept the market positive.

In June 2026, Paracetamol (Acetaminophen) price in India fell by 1.66% because buying slowed down after restocking. Stock levels. Buyers became more careful, about how they bought at the end of the quarter.

Spain: Paracetamol (Acetaminophen) Imported prices CIF Valencia from India, Spain; Pharma Grade (EP) (>99%) (POWDER)

In Q2 2026 the Paracetamol (Acetaminophen) Price in Spain increased by 7% compared to the previous quarter. The Paracetamol (Acetaminophen) Price Trend in Spain stayed firm. This stability came from pharmaceutical demand and regular import needs, which supported CIF pricing.

Importers kept buying Paracetamol (Acetaminophen) to meet the needs of manufacturing and formulation. At the time higher international prices for Paracetamol (Acetaminophen) raised landed costs. The Paracetamol (Acetaminophen) Price Chart showed a rise during the quarter. The Paracetamol (Acetaminophen) Price Index remained thanks to consistent consumption and ongoing import activity.

Freight costs and global supply conditions also played a role in pushing up CIF quotes. These factors helped drive the rise in import prices. In June 2026, Paracetamol (Acetaminophen) Price in Spain went up by around 0.5% from the month. This small increase showed a strengthening, in market values.

USA: Paracetamol (Acetaminophen) Imported prices CIF New York from India, USA; Pharma Grade (USP) (>99%) (POWDER)

In Q2 2026, Paracetamol (Acetaminophen) Price in the USA has increased by approximately 5% compared with the previous quarter. The Paracetamol (Acetaminophen) Price Trend in the USA has remained firm as steady pharmaceutical demand and continued import requirements have supported CIF pricing.

Importers have maintained procurement activity to meet downstream requirements, while higher international prices and associated landed costs have contributed to the upward movement. The Paracetamol (Acetaminophen) Price Chart has reflected a moderate increase during the quarter, while the Paracetamol (Acetaminophen) Price Index has remained supported by stable demand from pharmaceutical manufacturers and distributors.

Import costs, freight conditions, and international supply dynamics have continued to influence CIF quotations in the US market. In June 2026, Paracetamol (Acetaminophen) Prices in the USA have declined by around 1% compared with the previous month, indicating a slight correction as buying interest has moderated.

Vietnam: Paracetamol (Acetaminophen) Imported prices CIF Haiphong from China, Vietnam; Pharma Grade (USP) (>99%) (POWDER)

In Q2 2026 the Paracetamol (Acetaminophen) price in Vietnam rose by 4% compared with the earlier quarter. The Paracetamol (Acetaminophen) price trend in Vietnam stayed firm because demand for medicines stayed steady and regular shipments kept CIF prices stable.

Importers kept buying Paracetamol (Acetaminophen) to supply pharmaceutical makers while world prices of Paracetamol (Acetaminophen) pushed up the cost of arriving goods. The price chart for Paracetamol (Acetaminophen) showed a rise during the quarter and the price index for Paracetamol (Acetaminophen) is kept up by steady usage and imports.

Shipping costs and freight also shaped import costs keeping CIF quotes stable. In June 2026, Paracetamol (Acetaminophen) price in Vietnam increased by 1% compared with May showing a small rise, in market value.

Brazil: Paracetamol (Acetaminophen) Imported prices CIF Santos from China, Brazil; Pharma Grade (USP) (>99%) (POWDER)

In Q2 2026, Paracetamol (Acetaminophen) Price in Brazil has increased by approximately 10% compared with the previous quarter. The Paracetamol (Acetaminophen) Price Trend in Brazil has remained firm as higher import costs and steady pharmaceutical-sector demand have supported market pricing.

Importers have maintained regular procurement to meet downstream requirements, while elevated international Paracetamol (Acetaminophen) values have contributed to the increase in CIF prices. The Paracetamol (Acetaminophen) Price Chart has reflected a clear upward movement during the quarter, while the Paracetamol (Acetaminophen) Price Index has remained supported by stable buying interest and relatively firm import economics.

Freight and logistics conditions have also influenced the landed cost of Paracetamol (Acetaminophen) in Brazil, adding some pressure to import quotations. In June 2026, Paracetamol (Acetaminophen) Prices in Brazil have declined by around 1% compared with the previous month as buying activity has moderated slightly and importers have adopted a more cautious procurement approach.

Paracetamol (Acetaminophen) Price Trend Analysis: Q1 2026

Paracetamol Price Trend Q1 2026

During the first quarter of 2026, there emerged a distinct difference in terms of market recovery of Paracetamol (Acetaminophen) between India and China, as the market dynamics have been influenced by differences in the supply and demand dynamics within these key regions where Paracetamol is produced.

India posted strong gains in price amid recovery in demand, reduction in inventories, and continued purchases by pharmaceutical companies during the quarter. On the other hand, China is relatively stable with minor gains in paracetamol price trend, due to stable production levels and demand for exports that minimized fluctuations.

There is only slight improvement in export demand during the month of March. Despite the generally weak sentiments in the previous quarter, there has now been a shift towards stable-to-strong sentiments in the current period.

China: Paracetamol (Acetaminophen) Export Prices FOB Tianjin, China, Pharma Grade (USP) (>99%) (POWDER)

The Paracetamol price in China saw little changes in the first quarter of 2026, rising just by 0.25% on quarterly basis. This stability has been attributed to strong supply-demand factors, with sustained production volumes, stable export demand from key international customers. There are no interruptions in operations, as companies continued with stable output, whereas demand is cautious.

The paracetamol price trend in China in Q1 2026 saw little fluctuations, due to ample supply of stocks, along with competitive pricing. In March 2026, Paracetamol (Acetaminophen) prices in China witnessed a rise of 2.45% due to better inquiry level for exports, and stronger demand abroad.

India: Paracetamol (Acetaminophen) Domestically Traded prices in Ex-Vadodara, India, Pharma Grade (IP) (>99%) (POWDER)

According to Price Watch™ , in Q1 2026, Paracetamol (Acetaminophen) prices in India witnessed a recovery phase, increasing 4.88% compared to the previous quarter after a prolonged period of decline. The upward movements are supported by improved domestic demand and gradual stock absorption, as buyers resumed procurement beyond hand-to-mouth purchasing.

Additionally, steady production levels alongside better offtake from pharmaceutical manufacturers contributed to firmer market sentiment. The paracetamol price trend in India during the quarter reflected a shift from the earlier bearish phase, with tightening availability in certain segments and stabilization in export inquiries aiding price support.

In March 2026, acetaminophen prices in India increased further with 6.70% rising sharply during the month, driven by stronger buying interest and continued inventory correction. Overall, the market indicated a positive turnaround, with demand recovery expected to support prices in the near term.

Paracetamol (Acetaminophen) Price Trend Analysis 2025

Paracetamol (Acetaminophen) Price Trend Q1 2025

In Q1 2025, the Paracetamol (Acetaminophen) market across China and India displayed mixed but generally stabilizing behaviour, with overall pricing movement falling within a 0.5-12% range quarter-on-quarter. China recorded a sharper correction as weak global demand, uninterrupted production and competitive export conditions placed pronounced downward pressure on values, prompting formulators in key importing regions to adopt short-term procurement strategies and avoid long contractual commitments.

India, meanwhile, experienced a comparatively firmer tone supported by improved order volumes tied to new production cycles, export commitments, and slightly stronger inquiry levels from Africa and the Middle East. Stable manufacturing operations in both markets ensured ample availability, preventing volatility despite differing momentum. While India leaned mildly bullish and China remained distinctly bearish, overall sentiment stayed cautious and range bound as market participants monitored demand signals and awaited clearer price stabilization cues.

China: Pharma Grade (USP) (>99%) (POWDER) FOB Tianjin, Pharma Grade (USP) (>99%) (POWDER) Ex-Hebei

In Q1 2025, the market experienced another significant downward adjustment, with prices trending between USD 2,950-3,150 per metric ton and showing a 11.66% decline versus Q4. Weak global demand and highly competitive export dynamics resulted in deeper price pressure, especially in buyer-dominated regions.

Manufacturing operations in China continued uninterrupted, allowing ample supply to continue flowing into the marketplace. Formulators across Asia, Africa and Latin countries continued to procure cautiously, avoiding long-duration contracts and prioritizing short-term shipment cycles. The overall tone remained firmly bearish as participants monitored the market for a potential price floor.

India: Pharma Grade (IP) (>99%) (POWDER) Ex-Vadodara, Pharma Grade (IP) (>99%) (POWDER) Ex-Ludhiana, Pharma Grade (EP) (>99%) (POWDER) FOB Hyderabad ICD, Pharma Grade (USP) (>99%) (POWDER) FOB Nhava Sheva, Pharma Grade (USP) (>99%) (POWDER) CIF Valencia (INDIA), Pharma Grade (USP) (>99%) (POWDER) CIF New York (INDIA).

In Q1 2025, pricing continued with a mildly bullish tone as the market traded between USD 3000-3150 per metric ton, recording a 0.93% quarterly increase. Higher order volumes from pharmaceutical manufacturers linked to new production cycles and export delivery commitments reinforced a firmer price base. The market also observed slightly improved global inquiries, especially from Africa and the Middle East.

Stable operating rates at manufacturing facilities-maintained supply continuity, preventing any sharp escalation. While sentiment shifted towards optimism, the market remained fundamentally range-bound, with buyers continuing strategic procurement rather than speculative stocking.

Paracetamol (Acetaminophen) Price Trend Q2 2025

In Q2 2025, the Paracetamol (Acetaminophen) market across China and India continued trending downward with overall pricing declining in the 2-4% range as demand recovery remained limited and exports operated at moderate levels. Stable production rates, absence of supply disruptions, and steady cost inputs prevented any potential rebound while competitive offers particularly from China placed additional pressure on Indian negotiations.

Export activity also slowed, with buyers adopting a wait-and-watch approach amid expectations of further softening. Market sentiment overall remained cautious, and most procurement was aligned strictly with immediate consumption needs rather than speculative stocking, resulting in a persistently subdued trading environment through the quarter.

China: Pharma Grade (USP) (>99%) (POWDER) FOB Tianjin, Pharma Grade (USP) (>99%) (POWDER) Ex-Hebei

In Q2 2025, prices eased further into the USD 2,850-3,000 per metric ton range, reflecting a 3.65% decline from Q1. Even though the rate of decline slowed, the trend remained downward as demand recovery remained limited, and exports continued at moderate levels.

Production capacities remained steady, and the lack of supply disruptions prevented any rebound in values. Purchasing behaviour remained driven by immediate requirements, and most negotiations involved strong buyer-driven pricing strategies. With cost inputs stable and no new demand catalyst emerging, the market maintained a soft sentiment.

In Q2 2025, the market reversed its prior upward tendency as prices softened into the INR 2900-3000 per metric ton bracket, marking a 2.47% decline. Weakening demand from downstream pharmaceutical units, coupled with steady-to-surplus supply volumes, contributed to a softer price environment. Market participants monitored regional pricing closely, especially in China, where competitive offers encouraged downward negotiation pressure in India.

Export orders also reduced in size and frequency as international buyers waited for improved price benchmarks. Purchasing sentiment turned cautious, with most buyers preferring short-term replenishment aligned with actual consumption.

Paracetamol Price Trend Q3 2025

In Q3 2025, the global Paracetamol (Acetaminophen) market maintained a bearish tone, with both China and India reflecting weakening sentiment driven by persistent oversupply and restrained downstream purchasing. Across the two regions, prices declined within a 2-8% quarter-on-quarter range, influenced by competitive export offers, subdued formulation demand, and steady production output. High inventory levels, limited export traction, and cautious purchasing behaviour continued to weigh on pricing, while the absence of upstream cost support reinforced the ongoing correction trend.

Despite the downtrend, baseline pharmaceutical consumption and selective restocking helped limit sharper price erosion. Looking ahead, market sentiment remains cautious, with any potential recovery contingent on demand improvement, supply adjustments, and shifts in global export competitiveness.

China: Paracetamol (Acetaminophen) Pharma Grade (USP) (>99%) (POWDER) FOB Tianjin, Pharma Grade (USP) (>99%) (POWDER) Ex-Hebei

In Q3 2025, Paracetamol (Acetaminophen) prices fell further into the USD 2,650-2,800 per metric ton range, registering a 7.53% quarter-on-quarter decline and marking the lowest level observed in the reviewed period. Persistent global oversupply conditions, continued competitive export environments, and hesitant buying behaviour contributed significantly to the correction.

Downstream procurement remained muted as formulation plants operated with strategic inventory control, while traders avoided speculative stocking due to uncertainty about stabilization. With no upstream cost support or notable shift in demand fundamentals, market direction remained firmly bearish, and expectations pointed toward only gradual recovery contingent on improved consumption or notable supply restructuring.

India: Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (POWDER) Ex-Vadodara, Pharma Grade (IP) (>99%) (POWDER) Ex-Ludhiana, Pharma Grade (EP) (>99%) (POWDER) FOB Hyderabad ICD, Pharma Grade (USP) (>99%) (POWDER) FOB Nhava Sheva, Pharma Grade (USP) (>99%) (POWDER) CIF Valencia (INDIA), Pharma Grade (USP) (>99%) (POWDER) CIF New York (INDIA)

According to Price-Watch AI, In Q3 2025, Paracetamol (Acetaminophen) Pharma Grade (IP) (>99%) (POWDER) Ex-Vadodara prices extended their downward trajectory, stabilizing within USD 2800-2900 per metric ton, reflecting a 3.16% quarterly decline. Abundant inventory levels and consistent domestic production continued to outweigh demand, resulting in a subdued trading environment. Export momentum remained limited due to competitive global API supply and price sensitivity among major importing regions.

Operating conditions at manufacturing sites stayed steady, further anchoring supply-side pressure. Market sentiment remained bearish, with most stakeholders expecting limited upside unless triggered by a supply disruption, regulatory shift, or notable improvement in downstream pharmaceutical consumption heading into the next quarter.

Paracetamol Price Trend Q4 2025

In Q4 2025, the global Paracetamol (Acetaminophen) market remained under pressure, as prices in both China and India continued to soften amid ongoing oversupply and cautious downstream demand. Across the two regions, quarter-on-quarter price declines of roughly 2-4% were observed largely driven by high inventory levels, aggressive export pricing and subdued buying from formulation manufacturers.

Production levels stayed stable and the lack of upward movement in upstream costs further supported the downward price adjustment. Although routine pharmaceutical demand and selective restocking offered some support overall market sentiment remained cautious. Looking ahead, the outlook stayed subdued with any potential recovery dependent on a rebound in demand, supply-side discipline or changes in global trade competitiveness.

China: Paracetamol (Acetaminophen) Export Prices FOB Tianjin, China, Pharma Grade (USP) (>99%) (POWDER)

In Q4 2025, Paracetamol (Acetaminophen) prices in China moved in the range of USD 2,650-2,720 per metric ton posting a quarter-on-quarter decline of 1.90%. While the rate of price erosion slowed compared with the previous quarter, underlying market conditions remained weak, largely due to persistent global oversupply and subdued export demand.

Downstream buyers continued to adopt a cautious procurement approach, drawing down existing stocks and covering only near-term requirements. Production levels at major manufacturing units stayed stable, limiting any scope for supply tightening. In the absence of clear demand recovery signals, the market ended the quarter with a bearish to range-bound outlook.

India: Paracetamol (Acetaminophen) Domestically Traded prices in Ex-Vadodara, India, Pharma Grade (IP) (>99%) (POWDER)

According to Price Watch™, in Q4 2025, Paracetamol (Acetaminophen) prices in India continued to weaken, settling into a lower consolidated range of USD 2730-2770 per metric ton and recording a 4.18% quarter-on-quarter decline.

The extended correction was driven by comfortable domestic supply, elevated carryover stocks, and subdued export demand in the face of intense global API competition. Production rates remained largely unchanged, sustaining pressure on the supply side, while buyers largely limited purchases to immediate requirements.

Although pharmaceutical consumption remained steady, it was not strong enough to absorb excess volumes, leaving market sentiment bearish with little near-term upside in sight.

Paracetamol (Acetaminophen) Price Trend Analysis 2024

Paracetamol (Acetaminophen) Price Trend Q1 2024

In Q1 2024, the Paracetamol (Acetaminophen) Pharma Grade market across China and India showed contrasting movements, resulting in an overall price fluctuation within an 1-8% quarterly range. China experienced a mildly positive trend supported by steady export orders, improved inquiries from formulation sectors in Southeast Asia and the Middle East, and predictable supply chain conditions, allowing suppliers to maintain firmer offers despite only moderate demand.

In contrast, India saw a notable decline as high inventory carryover, subdued export momentum, and restrained procurement from formulation units weakened pricing sentiment. Both regions maintained stable production rates with no supply disruptions, but purchasing behaviour diverged-China benefitted from seasonal and export-linked activity, while India remained driven by short-term requirements and conservative stocking strategies.

Despite these differing regional dynamics, market sentiment overall remained cautious, with buyers closely monitoring cost conditions and demand recovery signals moving into the next quarter.

China: Pharma Grade (USP) (>99%) (POWDER) FOB Tianjin, Pharma Grade (USP) (>99%) (POWDER) Ex-Hebei

In Q1 2024, Paracetamol (Acetaminophen) Pharma Grade prices in China started the year on a slightly firmer note, moving within the USD 4,100-4,250 per metric ton range and registering a 1.61% increase compared to the prior quarter. The uptrend was primarily influenced by steady export orders and improved inquiries from formulation sectors in Southeast Asia and the Middle East.

Production rates remained consistent, but some manufacturers reported longer dispatch schedules due to heightened export booking cycles. Although demand was not aggressively strong, the balance between supply and movement allowed sellers to maintain relatively firm offers. Market sentiment leaned mildly positive, supported by predictable supply chains, stable feedstock availability, and a slight seasonal uplift in procurement.

In Q1 2024, Paracetamol (Acetaminophen) Pharma Grade prices in India softened notably, reflecting a bearish start to the year amid restrained purchasing and sufficient stock availability across the value chain. Prices moved within the USD 3050-3200 per metric ton range, registering a 8.79% decline as inventory carried forward from late 2023 reduced urgency among buyers. Domestic producers maintained consistent operating rates, ensuring uninterrupted supply and reducing the likelihood of market tightness. Export inquiries remained lukewarm, particularly from South Asia and Africa, where buyers leaned toward shorter purchasing cycles. With no upstream cost push and sluggish consumption from formulation units, sentiment stayed weak and transactional behaviour remained conservative.

Paracetamol (Acetaminophen) Price Trend Q2 2024

In Q2 2024, the Paracetamol (Acetaminophen) market across China and India underwent a pronounced correction, with overall pricing declining within a 4-14% range quarter-on-quarter as bearish sentiment strengthened. China saw steeper declines driven by aggressive export pricing, slowed global offtake, and inventory accumulation across trading networks, prompting buyers to delay large-volume commitments. India mirrored the downward momentum, though at a milder pace, as steady supply inflows, moderate production rates, and competitive regional offers continued to pressure domestic pricing.

Downstream pharmaceutical manufacturers in both markets shifted to cautious, demand-based purchasing strategies amid expectations of further easing, while stable raw material costs provided no upward push. With ample production capacity, controlled logistics, and limited export strength, transactional activity remained subdued, reinforcing expectations of continued softening in the short term.

China: Pharma Grade (USP) (>99%) (POWDER) FOB Tianjin, Pharma Grade (USP) (>99%) (POWDER) Ex-Hebei

In Q2 2024, the pricing environment shifted sharply downward as values corrected to the USD 3,500-3,750 per metric ton range, marking a significant 13.38% decline from Q1. The drop was triggered by aggressive competitive pricing from multiple Chinese exporters and slow offtake from key global destinations.

Inventory buildup across trading houses and bulk formulators deepened discounts, as many buyers refrained from committing to large-volume contracts. Weak downstream consumption and reduced purchasing momentum across Europe and South Asia contributed to subdued transactional activity. With ample production and no supply disruptions, sentiment turned decisively bearish, reinforcing expectations of continued downward pressure.

In Q2 2024, the downward trajectory continued as the market entered another corrective phase, with prices fluctuating within USD 2950-3050 per metric ton, reflecting a 4.22% quarterly decline. The market experienced steady supply inflows and moderate production rates, which supported price competition among producers and traders. Downstream pharmaceutical manufacturers continued purchasing on a need-basis to avoid overstocking amid expectations of further easing. Raw material costs, including para-aminophenol, remained largely stable, offering no cost-side support. Export momentum remained stable but not strong enough to shift market balances, while competitive offers from regional suppliers kept Indian prices under pressure.

Paracetamol (Acetaminophen) Price Trend Q3 2024

In Q3 2024, the Paracetamol (Acetaminophen) market across China and India moved into a stabilization phase, with overall pricing showing limited movement within a 0-0.5% range quarter-on-quarter. In China, prices recorded a modest uptick as buyers cautiously resumed scheduled procurement tied to production cycles, while manufacturers maintained controlled output to avoid renewed oversupply. Export interest gradually improved, particularly from generic drug formulators in Latin America and Africa, though purchasing remained highly price-sensitive.

In India, pricing remained stable with no major deviation from the previous quarter as inventory levels normalized and production operated in alignment with demand trends. Consistent domestic availability and steady import flows kept negotiation spreads narrow, while reduced volatility in both regions signaled a temporary market equilibrium driven by balanced supply, moderated demand, and disciplined purchasing strategies.

China: Pharma Grade (USP) (>99%) (POWDER) FOB Tianjin, Pharma Grade (USP) (>99%) (POWDER) Ex-Hebei

In Q3 2024, the market entered a stabilization phase as prices steadied within the USD 3,600-3,750 per metric ton range, reflecting a modest 0.41% increase from the previous quarter. Buyers returned to the market cautiously after the earlier sharp decline, initiating scheduled procurement tied to production cycles rather than speculative stocking.

Export inquiries showed gradual improvement, especially from generic drug manufacturers in Latin America and Africa, though purchasing remained price sensitive. Manufacturers maintained disciplined output to prevent further oversupply. As inventories normalized and demand steadied, the market saw reduced volatility and narrower negotiation spreads, creating a temporary equilibrium.

In Q3 2024, pricing stabilized following two consecutive quarters of decline, moving within the USD 2950-3050 per metric ton bracket remained stable marking no change from the previous quarter. Inventory levels across primary distributors and formulation facilities reached a steady equilibrium, easing volatility and narrowing negotiation margins.

Domestic production continued uninterrupted, with utilization rates aligned to demand trends to prevent oversupply. The availability of imported material remained consistent, though it did not influence pricing significantly due to logistics, quality preferences, and lead-time considerations. With balanced supply and moderate procurement activity, the market saw minimal deviation in spot and contracted transaction levels.

Paracetamol (Acetaminophen) Price Trend Q4 2025

In Q4 2024, the Paracetamol (Acetaminophen) market across China and India reflected a mixed but largely stable trend, with overall price movement falling within a 0.5%-5% quarterly range. In China, pricing softened amid steady production, sluggish export momentum, and buyer-driven negotiations as pharmaceutical manufacturers remained cautious and continued short-term procurement strategies due to expectations of further easing.

Meanwhile, India saw marginal upward movement supported by restocking ahead of year-end production cycles, seasonal consumption linked to analgesic and antipyretic formulations, and steady export participation. Controlled logistics and operating costs prevented significant volatility in both regions, while stable raw material inputs offered modest cost support. Despite contrasting regional behaviour, overall market sentiment remained cautious and competitive as participants monitored oversupply conditions, pricing discipline, and the balance between export activity and domestic demand heading into the next quarter.

China: Pharma Grade (USP) (>99%) (POWDER) FOB Tianjin, Pharma Grade (USP) (>99%) (POWDER) Ex-Hebei

In Q4 2024, prices softened again, declining into the USD 3,300-3,500 per metric ton band and recording a 5.21% quarterly decrease. A combination of steady production rates and sluggish export momentum continued to weigh on pricing. Pharmaceutical manufacturers maintained careful purchasing strategies due to steady availability and expectations of further easing.

Logistics and operating costs remained controlled, offering no upward cost traction. Despite the falling trend, trade volumes remained consistent due to year-end contract fulfilments and export participation in tenders. However, the broader sentiment stayed cautious as the market continued adjusting to oversupply and price competition.

In Q4 2024, Paracetamol (Acetaminophen) prices showed marginal upward movement into the USD 3000-3100 per metric ton range, reflecting a 0.94% increase from Q3. The rise was supported by restocking demand ahead of the year-end production cycle and stable export activity from India. Seasonal consumption trends associated with analgesic and antipyretic medicines also contributed to stronger procurement behaviour.

While upstream raw material fluctuations were minor, they provided modest cost support, contributing to the gradual upward shift. Despite this recovery, pricing remained contained due to well-balanced domestic supply and cautious purchasing strategies from finished dosage manufacturers.

Technical Specifications of Paracetamol (acetaminophen) Price Trends

Product Description:

Paracetamol (Acetaminophen) is a widely used analgesic and antipyretic medication essential for managing mild to moderate pain and reducing fever in various conditions such as headaches, muscle aches, toothaches, colds, flu, and post-surgical discomfort. It works primarily by inhibiting prostaglandin synthesis in the central nervous system and regulating body temperature through action on the hypothalamus. Unlike nonsteroidal Anti-inflammatory drugs paracetamol does not irritate the gastric lining and has no significant anti-inflammatory effects making it suitable for individuals who cannot tolerate aspirin or similar medications. It is commonly used across all age groups due to its favourable safety profile when taken within recommended dosage limits; however, excessive or prolonged use may lead to liver toxicity, particularly in individuals with liver disease or those consuming alcohol. Paracetamol (Acetaminophen) is available in multiple dosage forms, including tablets, capsules, syrups, suspensions, suppositories and injectable formulations, making it versatile and effective for diverse therapeutic applications.

Identifiers and Classification:

HS Code – 29222933
CAS No – 103-90-2
Molecular Formula – C₈H₉NO₂
Molecular Weight[g/mol] – 151.163 g/mol

Paracetamol (Acetaminophen) Synonyms:

Acetaminophen
Tylenol
Nonsteroidal Anti-inflammatory

Paracetamol (Acetaminophen) Grades Specific Price Assessment:

Pharma Grade (IP) (>99%) (POWDER) Ex-Vadodara Price Trend
Pharma Grade (IP) (>99%) (POWDER) Ex-Ludhiana Price Trend
Pharma Grade (EP) (>99%) (POWDER) FOB Hyderabad ICD Price Trend
Pharma Grade (USP) (>99%) (POWDER) FOB Nhava Sheva Price Trend
Pharma Grade (USP) (>99%) (POWDER) CIF Valencia (INDIA) Price Trend
Pharma Grade (USP) (>99%) (POWDER) CIF New York (INDIA) Price Trend
Pharma Grade (USP) (>99%) (POWDER) Ex-Hebei Price Trend
Pharma Grade (USP) (>99%) (POWDER) FOB Tianjin Price Trend
Pharma Grade (USP) (>99%) (POWDER) CIF Haiphong (CHINA) Price Trend
Pharma Grade (USP) (>99%) (POWDER) CIF Santos (CHINA) Price Trend

Paracetamol (Acetaminophen) Global Trade and Shipment Terms

Quotation Terms (Product & Country Specific): 25-30 MT
Packaging Type (Product & Country Specific): Bag (25KGs)

Incoterms Referenced in Paracetamol (Acetaminophen) Price Reporting

Shipping Term	Location	Definition
Ex-Vadodara	Gujarat, India	Domestically Traded Paracetamol (Acetaminophen) price in India
Ex-Ludhiana	Punjab, India	Domestically Traded Paracetamol (Acetaminophen) price in India
FOB Hyderabad	Telangana, India	Paracetamol (Acetaminophen) Export price from India
FOB Nhava Sheva	Mumbai, India	Paracetamol (Acetaminophen) Export price from India
CIF Valencia (INDIA)	Valencia, Spain	Paracetamol (Acetaminophen) Import price in Spain from India
CIF New York (INDIA)	New York, USA	Paracetamol (Acetaminophen) Import price in USA from India
Ex-Hebei	Hebei, China	Domestically Traded Paracetamol (Acetaminophen) price in China
FOB Tianjin	Tianjin, China	Paracetamol (Acetaminophen) Export price from India
CIF Haiphong (CHINA)	Haiphong, Vietnam	Paracetamol (Acetaminophen) Import price in Vietnam from China
CIF Santos (CHINA)	Santos, Brazil	Paracetamol (Acetaminophen) Import price in Brazil from China

*Quotation Terms refers to the quantity range specified for the Paracetamol (Acetaminophen) being quoted or offered in a commercial transaction.

**Packaging Type refers to standard packaging size commonly used for Paracetamol (Acetaminophen) packing, ease of handling, transportation, and storage in industrial and commercial applications.

Key Paracetamol (Acetaminophen) Producing Regions and Countries

Region	Country
Gujarat	India
Punjab	India
Telangana	India
Mumbai	India
Valencia	Spain
New York	USA
Hebei	China
Tianjin	China
Haiphong	Vietnam
Santos	Brazil

Paracetamol (acetaminophen) Industrial Applications

Historical paracetamol (acetaminophen) Price Trend Analysis

Historically, several events have caused significant fluctuations in Paracetamol (acetaminophen) prices

Impact ofUS Tariffs on Paracetamol (Acetaminophen) (2025)

The US tariffs placed in 2025 on acetaminophen and other pharmaceutical APIs from China and India, totalling 20-25% of raw materials and intermediates, have dramatically increased production costs for enterprises who rely on these imports. This has resulted in API cost hikes of 12-20%, adding to increasing medicine pricing and reducing profit margins for generic producers who rely significantly on low-priced Asian supplies. Tariffs have also put pressure on supply chains by encouraging pharmaceutical companies to diversify their sourcing or invest in onshore or nearshoring production facilities in the United States and other lower-tariff jurisdictions, but such shifts are time-consuming and fraught with regulatory challenges, keeping supply constrained in the short term. These trade sanctions have caused price volatility and supply delays serving the US market.

COVID-19 Pandemic Boosts Paracetamol Use (2020-2022)

During the global COVID-19 pandemic, paracetamol became a commonly recommended treatment for decreasing fever and treating pain in individuals infected with SARS-CoV-2. It was the first-line treatment due to its availability over-the-counter and relative safety. Due to extended or excessive use during the pandemic, this increase in use raised awareness of the possible risks of overdose and liver toxicity.

Chinese PAP Export Disruptions (2018-2020)

From 2018 to 2020, China-supplying over 70% of global para-aminophenol (PAP), the critical raw material for paracetamol-implemented tightened export controls under its 2020 Export Control Law, which regulated dual-use chemicals like PAP for national security, non-proliferation and anti-terrorism purposes requiring prior licenses that caused shipment delays and reductions. Geopolitical factors, including US-China trade tensions, environmental factory shutdowns, and rising domestic paracetamol demand in China, exacerbated supply constraints, leading to up to 50% price surges and production halts for India. This triggered global paracetamol shortages, higher pharmaceutical costs and spurred diversification like India’s anti-dumping probes and backward integration with volatility persisting into 2025.

S.-China Trade War (2018-2019)

In 2018, rising trade tensions between the United States and China started to impact pharmaceutical manufacturing and supply chains significantly. The U.S. implemented tariffs targeting Chinese chemical imports, including key pharmaceutical ingredients like para-aminophenol, essential for producing paracetamol. These tariffs increased costs and caused delays, posing challenges for manufacturers reliant on Chinese supplies. Meanwhile, the trade conflict encouraged companies to seek alternative suppliers and reconsider their supply strategies amid uncertain geopolitical conditions. This period marked the beginning of a broader shift in the global pharmaceutical industry to diversify supply chains and reduce dependency on any single country.

Global Shortages from Manufacturing Inspections (2018)

In 2018, the FDA significantly intensified inspections of pharmaceutical manufacturing plants, especially those producing active pharmaceutical ingredients (APIS) overseas. Several facilities, particularly in India and China were found to have serious good manufacturing practice (GMP) violations such as contamination risks, inadequate quality controls and poor documentation. These discoveries led to import alerts and bans on shipments from these plants to the U.S. market, resulting in acute shortages of essential medicines like paracetamol.

Hospitals and healthcare providers faced challenges due to these shortages, as domestic production capacity was insufficient to compensate quickly. The events highlighted the pharmaceutical industry’s heavy reliance on foreign manufacturing and underscored the need for improved quality oversight and supply chain diversification to prevent similar disruptions in the future. The increased scrutiny also prompted manufacturers to enhance their compliance efforts and invest in supply chain resilience measures.

Why Price Watch™?

Price Watch™ is your trusted resource for tracking global paracetamol (acetaminophen) price trends. Our platform delivers real-time data and expert analysis, offering deep insights into the key factors driving price fluctuations in the paracetamol (acetaminophen) market. By monitoring critical events such as geopolitical tensions, supply chain disruptions, and economic shifts, Price Watch™ keeps you fully informed of market dynamics.

In addition, Price Watch™ provides detailed forecasts and updates on production capacities, enabling you to anticipate market changes and make well-informed decisions. With Price Watch™, you gain a competitive edge in understanding all the elements that influence paracetamol (acetaminophen) prices worldwide. Stay ahead of the curve with Price Watch’s™ reliable, accurate, and timely paracetamol (acetaminophen) market data.

Track Price Watch's™ paracetamol (acetaminophen) price assessment on a weekly basis since 2015 onwards, along with short-term forecasts, and get access to the detailed report in a downloadable format.

Disclaimer

Paracetamol (acetaminophen) Market Price Trend published by Price Watch™ reflect prevailing spot market conditions, derived from independent research, verified trade inputs, and proprietary market intelligence as of the publication date. Prices are published on the specified Incoterm and represent indicative base market levels, exclusive of applicable taxes, VAT, duties, tariffs, and other statutory charges. Actual transaction values may vary depending on volume, credit terms, contractual structure, and other negotiated conditions. Market prices are inherently subject to volatility, liquidity dynamics, regulatory changes, and evolving trade activity. The information provided is for reference and benchmarking purposes only and does not constitute an offer, recommendation, or guarantee of transactional outcomes. Users should exercise independent commercial judgment and assess their specific contractual, regulatory, tax, and application requirements before making business decisions. Price Watch™ assumes no liability for decisions taken based on this information.

FAQ

What are the key factors influencing Paracetamol (Acetaminophen) pricing? +

Paracetamol (Acetaminophen) Pricing Factors: Paracetamol (Acetaminophen) pricing is shaped by a combination of global manufacturing capacity, supply-demand balances, pharmaceutical industry demand and raw material availability, especially in key producing regions such as China and India.

Production output for Paracetamol (Acetaminophen) depends on access to chemical precursors, plant capacity utilization and regulatory practices governing pharmaceutical standards, all of which directly influence supply expectations.

Market direction is heavily driven by demand from pharmaceutical sector with additional volatility created by inventory levels and export competitiveness among major suppliers.

How can I negotiate favourable Paracetamol (Acetaminophen) pricing with suppliers? +

Negotiating Paracetamol (Acetaminophen) Pricing: Leverage market knowledge: Keep up to date with global Paracetamol (Acetaminophen) supply trends, demand cycles and pricing benchmarks to negotiate with confidence.

Pursue long-term contracts: Lock in pricing and ensure secure supply by entering agreements during low-price cycles, particularly in volatile periods.

Diversify sourcing: Compare quotes from multiple suppliers across regions to strengthen negotiation positions and hedge against local supply disruptions.

Foster supplier relationships: Develop trust and consistent communication to receive priority access and flexible terms in constrained supply scenarios.

Optimize logistics: Negotiate shipping terms and consider cost-effective delivery modes, as transport delays and freight charges heavily influence landed costs.

What are the potential risks associated with Paracetamol (Acetaminophen) procurement, and how can I mitigate them? +

Paracetamol (Acetaminophen) Procurement Risks and Mitigation: Price volatility: Paracetamol (Acetaminophen) prices are tied to CPO values and affected by global market sentiment and trade policy changes. Mitigation: Implement hedging strategies (e.g., futures, fixed contracts) and monitor pricing trends for timely purchases.

Supply disruptions: Weather anomalies, plant shutdowns, and freight congestion can result in delivery delays or shortages. Mitigation: Diversify suppliers geographically, maintain inventory buffers, and keep close tabs on climatic and operational updates.

Quality variability: Differences in moisture content and impurities foreign matter presence can affect suitability for downstream applications. Mitigation: Enforce detailed product specifications, request COAs, and audit supplier production processes regularly.

Regulatory and currency risks: Trade policies and currency movements directly impact import costs.
Mitigation: Monitor regional trade policy developments and use currency hedging mechanisms when sourcing internationally.

Robust risk mitigation strategies and solid supplier alliances are essential for ensuring a reliable, cost-effective paracetamol (acetaminophen) supply.

What is Paracetamol (Acetaminophen) and why does its price matter? +

Paracetamol (Acetaminophen) is one of the most widely used analgesic and antipyretic pharmaceutical ingredients, used to relieve pain and reduce fever. It is a core active ingredient in numerous over-the-counter (OTC) and prescription formulations, including tablets, syrups, suspensions, and combination drugs.

Its price directly impacts medicine affordability, pharmaceutical manufacturing costs, public healthcare spending and procurement budgets for hospitals and government health programs.

Because of its essential role in primary healthcare worldwide, Paracetamol pricing is a critical indicator for pharmaceutical supply chains. Price Watch™ tracks these prices to help businesses and consumers understand and stay updated with the market trends.

How much does Paracetamol (Acetaminophen) cost right now? +

Paracetamol (Acetaminophen) prices vary by region and grade. Prices are typically quoted per metric ton and change based on supply, demand, production methods, and energy costs. Price Watch™ provides real-time price assessments across different global markets to help buyers and sellers make informed decisions.

What is the market trend in Paracetamol (Acetaminophen), and what affects Paracetamol (Acetaminophen) prices? +

Paracetamol prices are influenced by upstream raw material costs (such as Para-Aminophenol), production operating rates, inventory levels, export competitiveness and downstream pharmaceutical demand. Regulatory compliance costs, environmental norms, energy prices, freight rates, and global healthcare demand cycles also affect pricing. Demand surges during flu seasons, pandemics, or public health emergencies can tighten supply and lift prices, while oversupply and weak formulation demand can lead to price corrections.

Which industries buy the most Paracetamol (Acetaminophen)? +

The largest buyers of Paracetamol are pharmaceutical formulation companies producing tablets, syrups, capsules, and combination drugs. Significant demand also comes from OTC drug manufacturers, contract manufacturing organizations (CMOS), government healthcare procurement agencies, hospitals, and export-oriented pharmaceutical companies. Price Watch™ analyses demand patterns across all these industries.

Where does Paracetamol (Acetaminophen) come from? +

Paracetamol is synthesized through chemical processes using Para-Aminophenol as the key intermediate. It is manufactured by pharmaceutical API producers worldwide, with major production hubs in China and India, supported by integrated chemical supply chains, skilled manufacturing capacity, and large-scale export infrastructure.

Who is the largest exporter of Paracetamol (Acetaminophen)? +

China and India are the world’s largest exporters of Paracetamol, supplying bulk API to pharmaceutical companies across Asia, Europe, Africa, and the Americas. Export volumes depend on production capacity, regulatory approvals, cost competitiveness, currency movements, and global healthcare demand. Price Watch™ tracks production levels, export flows and trade patterns to help businesses understand global supply chains and identify sourcing opportunities.

Is there enough Paracetamol (Acetaminophen) to meet global demand? +

Under normal conditions, supply generally meets demand. However, shortages can occur due to plant shutdowns, regulatory inspections, raw material disruptions, environmental compliance issues, or sudden demand spikes during health emergencies. Price Watch™ monitors these supply-demand imbalances to alert the market about potential shortages or surpluses.

What are the different grades of Paracetamol (Acetaminophen) and why do prices differ? +

Paracetamol is available in multiple pharmacopeial grades, including IP, BP, USP and EP, each with specific purity and compliance requirements. Higher-purity grades and those meeting stringent regulatory standards command premium prices.

Pricing also varies based on particle size, formulation suitability, manufacturing consistency, certifications, and audit readiness. Export-oriented and regulated-market grades typically trade at higher prices than domestic or non-pharma specifications. Price Watch™ provides separate price assessments for each grade to ensure market transparency.

What happens when demand for Paracetamol (Acetaminophen) suddenly increases? +

When demand spikes often during flu seasons, pandemics or public health emergencies prices typically rise as inventories tighten and lead times extend. Manufacturers may prioritize long-term or government contracts, while spot buyers may face higher prices or limited availability. Price Watch™ captures these market dynamics in real-time.

How do energy prices affect Paracetamol (Acetaminophen) costs? +

Energy costs significantly influence Paracetamol production, as chemical synthesis, drying, and quality control processes are energy intensive. Rising electricity, fuel, or steam costs increase manufacturing expenses, which are often passed on to buyers.

Transportation and export logistics further amplify energy-related cost impacts. Price Watch™ analyses in its price assessments & market reports.

What causes regional price differences for Paracetamol (Acetaminophen)? +

Regional price differences arise from variations in production capacity, regulatory compliance costs, raw material availability, labor and energy costs, freight rates, currency movements, and local demand conditions.

Regions with integrated chemical supply chains and strong export infrastructure generally offer more competitive pricing, while regulated markets often see higher prices. Price Watch™ tracks prices across all major regions to highlight these differences.

What is the forecast for Paracetamol (Acetaminophen) prices? +

The Paracetamol (Acetaminophen) market outlook depends on raw material trends, global healthcare demand, production operating rates, regulatory developments, freight costs, and macroeconomic conditions. Seasonal demand patterns and potential supply side disruptions also play a role.

Price Watch™ regularly publishes detailed forecasts that project price movements for the next 12 months based on comprehensive analysis of supply additions, demand growth in key industries, seasonal patterns, and macroeconomic indicators. Our forecasts help businesses anticipate market conditions and plan accordingly.

Can Paracetamol (Acetaminophen) price forecasts really help my business? +

Absolutely. Reliable forecasts help pharmaceutical companies and traders optimize procurement timing, negotiate contracts more effectively, manage inventory risks, and improve budgeting accuracy. If Price Watch™ forecasts predict a price increase in three months, you might choose to stock up now or lock in long-term contracts at current rates, potentially saving thousands of dollars.

How do global events impact Paracetamol (Acetaminophen) supply and prices? +

Global events such as pandemics, regulatory crackdowns, environmental inspections, raw material shortages, logistics disruptions, trade restrictions or geopolitical tensions can significantly impact Paracetamol supply and pricing. Sudden surges in healthcare demand or export limitations can trigger sharp price movements. Price Watch™ provides timely alerts when such events affect the market.

Where can I find reliable Paracetamol (Acetaminophen) price information? +

Price Watch™ collects data from manufacturers, distributors, and buyers worldwide to publish regular price assessments, market reports, and forecasts. Our transparent methodology and comprehensive coverage make us a trusted source for understanding fair pricing and market trends in the Paracetamol (Acetaminophen) industry.